Nova Eye Medical Ltd (EYE.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2015 | 06-2014 | 06-2013 | 06-2012 | 06-2011 | |
| Cash Flows From Operating Activities | |||||
| Operating Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,446 | -1,016 | -592 | -211 | -484 |
| Net Acquisitions | N/A | -1,693 | N/A | N/A | N/A |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -7 |
| Purchase Sale Intangibles | -403 | -80 | -78 | -34 | -75 |
| Other Investing Activity | -2,317 | -2,055 | -2,215 | -1,285 | -1,397 |
| Investing Cash Flow | $-4,166 | $-4,844 | $-2,885 | $-1,530 | $-1,963 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,324 | 364 | N/A | 1,000 | 1,227 |
| Debt Repayment | -1,263 | -1,782 | -824 | -993 | -2,527 |
| Common Stock Issued | N/A | 5,929 | N/A | N/A | N/A |
| Other Financing Activity | -43 | -13 | -21 | -56 | -94 |
| Financing Cash Flow | $1,018 | $4,498 | $-845 | $-49 | $-1,394 |
| Exchange Rate Effect | -369 | -59 | 70 | -64 | 220 |
| Beginning Cash Position | 1,786 | -513 | 1,203 | 1,009 | 3,217 |
| End Cash Position | 4,593 | 1,786 | -513 | 1,203 | 1,048 |
| Net Cash Flow | $3,176 | $2,358 | $-1,786 | $258 | $-2,389 |
| Free Cash Flow | |||||
| Capital Expenditure | -4,209 | -3,161 | -2,899 | -1,599 | -1,985 |
| Free Cash Flow | -4,209 | -3,161 | -2,899 | -1,599 | -1,985 |